Asunaprevir
Products Asunaprevir is not currently registered in many countries. It has been approved in Japan since 2014 (Sunvepra, Bristol-Myers Squibb) and is used in combination with daclatasvir (Daklinza) as an interferon and ribavirin-free treatment. Structure and properties Asunaprevir (C35H46ClN5O9S, Mr = 748.3 g/mol) Effects Asunaprevir has antiviral properties. The effects are due to selective and … Asunaprevir